Nancy Shearey
Family · Orlando, FLNPI 1982114609
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by GSK at 28.1% of the total. Reporting peaked in 2021 at $1,924 and has fallen 99.2% since, to $15 in 2025.
Across 104 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$609
- AstraZeneca$282
- Grifols USA, LLC$268
- Genentech USA, Inc.$234
- Boehringer Ingelheim$103
- Regeneron Healthcare Solutions, Inc.$88
- plus $583 from 13 others
What the payments were for
- Food & beverage$2,167100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 32 | $609 |
| AstraZeneca | 13 | $282 |
| Grifols USA, LLC | 11 | $268 |
| Genentech USA, Inc. | 5 | $234 |
| Boehringer Ingelheim | 6 | $103 |
| Regeneron Healthcare Solutions, Inc. | 4 | $88 |
| Mallinckrodt Hospital Products Inc. | 4 | $84 |
| Electromed, Inc. | 4 | $78 |
| Sanofi | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $73 |
| Advanced Respiratory, Inc | 5 | $72 |
| Abbott | 3 | $50 |
| Novartis | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 2 | $34 |
| Bayer | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $15 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XOLAIR$162
- Esbriet$162
- Prolastin-C Liquid$133
- NUCALA$125
How this compares
$2,167 in reported general payments places this provider in the 80th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 11 | $7,546 |
| Alprazolam | 12 | $413 |
| Levothyroxine Sodium | 18 | $365 |
| Metoprolol Succinate | 12 | $340 |
| Lisinopril | 17 | $310 |
| Atorvastatin Calcium | 12 | $307 |
| Furosemide | 12 | $89 |
Paid to pharmacies, not to this prescriber.
Other family in Orlando
- Donna OrtizOrlando$417K
- Lindsey McCabeOrlando$37K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.